Startups.Bio showcases an emerging biotech startup each week, selected by the analyst team at VentureRadar from the 10,000s of companies we track.
Latest featured startups
Nuevocor is a preclinical-stage biotech company specializing in gene therapy for cardiomyopathies. The company’s lead programme is an adeno-associated virus (AAV) – based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the lamin A/C (LMNA) gene. The company also plans to address other untreatable cardiomyopathies using their novel target discovery platform. […]
View post to subscribe to site newsletter.
In the past three months we’ve featured 11 emerging biotech startups — selected from the VentureRadar Database — working on a range new approaches to tackling major diseases. You can find out more about all the companies in the summaries below. Cutanos Cutanos is developing dermal targeted delivery systems for novel vaccines and immunotherapies via […]
View post to subscribe to site newsletter.
Cutanos, a spin-off from the Max Planck Society, is developing dermal targeted delivery systems for novel vaccines and immunotherapies. Delivery of antigens to specialised immune cells, called dendritic cells (DCs), is a promising approach to developing innovative vaccines, as well as immunotherapies against cancer and autoimmune diseases. However, there are different subsets of DCs which […]
View post to subscribe to site newsletter.